uniQure N.V. Insider Trading Activity
Every SEC Form 4 insider transaction reported for uniQure N.V. (QURE), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are QURE insiders buying or selling?
In the last 12 months, uniQure N.V. insiders reported 0 open-market purchases ($0) and 34 sales ($22.1M) — net selling of $22.1M. Since January 2018, Trabud has recorded 244 Form 4 filings for QURE: 0 buys ($0) and 244 sells ($79.9M).
Source: SEC EDGAR Form 4
What stands out
- No uniQure N.V. insider made an open-market purchase in the last 12 months; the 34 reported open-market sales totaled $22.1M.
Key Statistics (January 2018 – Jul 7, 2026)
Total Form 4 filings
244
SEC EDGAR
Insider filers
24
Insider buys (0)
$0
Insider sells (244)
$79.9M
Insider sentiment
Net sellingNet insider flow of $79.9M in net selling since January 2018, and $22.1M in net selling over the last 12 months.
Recent QURE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 21.1K | $45.16 | $952.1K | SEC ↗ |
| Jul 2, 2026 | Walid Abi-Saab | Chief Medical Officer | Sale | 30.0K | $46.42 | $1.4M | SEC ↗ |
| Jul 2, 2026 | Jack Kaye | Director | Sale | 21.2K | $46.44 | $983.0K | SEC ↗ |
| Jun 30, 2026 | Walid Abi-Saab | Chief Medical Officer | Sale | 1.4K | $46.86 | $67.2K | SEC ↗ |
| Jun 26, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 35.4K | $50.02 | $1.8M | SEC ↗ |
| Jun 22, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 206.1K | $45.47 | $9.4M | SEC ↗ |
| Jun 22, 2026 | Madhavan Balachandran | Director | Sale | 11.7K | $45.06 | $526.5K | SEC ↗ |
| Jun 22, 2026 | Jack Kaye | Director | Sale | 5.3K | $42.57 | $225.4K | SEC ↗ |
| Jun 17, 2026 | Madhavan Balachandran | Director | Sale | 10.0K | $27.85 | $278.5K | SEC ↗ |
| Jun 17, 2026 | Jeannette Potts | Chief Legal Officer | Sale | 5.2K | $27.67 | $144.9K | SEC ↗ |
| Jun 12, 2026 | David D. Meek | Director | Sale | 2.0K | $27.06 | $53.9K | SEC ↗ |
| Jun 12, 2026 | Robert Gut | Director | Sale | 10.3K | $26.32 | $270.5K | SEC ↗ |
| Jun 12, 2026 | Kylie O'Keefe | Chief Customer & Strat Officer | Sale | 15.9K | $27.06 | $431.2K | SEC ↗ |
| Jun 12, 2026 | Jeremy P. Springhorn | Director | Sale | 2.0K | $27.06 | $53.9K | SEC ↗ |
| Jun 12, 2026 | Leonard E Post | Director | Sale | 2.0K | $27.06 | $53.9K | SEC ↗ |
| Jun 12, 2026 | Jack Kaye | Director | Sale | 2.0K | $27.06 | $53.9K | SEC ↗ |
| Jun 12, 2026 | Rachelle Suzanne Jacques | Director | Sale | 2.0K | $27.06 | $53.9K | SEC ↗ |
| Jun 12, 2026 | Madhavan Balachandran | Director | Sale | 2.0K | $27.06 | $53.9K | SEC ↗ |
| Jun 5, 2026 | Jack Kaye | Director | Sale | 2.6K | $30.01 | $79.4K | SEC ↗ |
| May 12, 2026 | Walid Abi-Saab | Chief Medical Officer | Sale | 45.0K | $25.06 | $1.1M | SEC ↗ |
| Mar 6, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 14.6K | $9.06 | $132.1K | SEC ↗ |
| Mar 6, 2026 | Walid Abi-Saab | Chief Medical Officer | Sale | 808 | $9.06 | $7.3K | SEC ↗ |
| Mar 6, 2026 | Jeannette Potts | Chief Legal Officer | Sale | 3.4K | $9.06 | $30.9K | SEC ↗ |
| Mar 6, 2026 | Christian Klemt | Chief Financial Officer | Sale | 12.0K | $9.06 | $108.7K | SEC ↗ |
| Mar 4, 2026 | Matthew C Kapusta | CEO, Managing Director | Sale | 34.4K | $9.95 | $342.6K | SEC ↗ |
Showing the 25 most recent of 244 Form 4 filings for uniQure N.V..
Most active QURE insiders
- Matthew C Kapusta55 filings
- Alexander Edward Kuta III29 filings
- Christian Klemt26 filings
- Robert Gut16 filings
- Jack Kaye15 filings
Ask anything about QURE insider activity
Use Trabud's AI agent to query uniQure N.V.'s Form 4 history in plain English — "Show me QURE CEO purchases this year" or compare it against any other ticker.
Open the AI agentQURE insider trading FAQ
Are uniQure N.V. insiders buying or selling?
In the last 12 months, uniQure N.V. insiders reported 0 open-market purchases ($0) and 34 sales ($22.1M) — net selling of $22.1M. Since January 2018, Trabud has recorded 244 Form 4 filings for QURE: 0 buys ($0) and 244 sells ($79.9M). Over the full record that is net selling of $79.9M.
How many insiders trade QURE stock?
24 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for uniQure N.V.. The most recent filing was accepted on Jul 7, 2026.
Where does Trabud get QURE insider trading data?
All QURE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.